7.3215
                                            Precision Biosciences Inc Aktie (DTIL) Neueste Nachrichten
Precision BioSciences (NASDAQ:DTIL) Announces Quarterly Earnings Results - MarketBeat
Detecting price anomalies in Precision BioSciences Inc. with AIJuly 2025 Earnings & Safe Capital Growth Tips - newser.com
Using economic indicators to assess Precision BioSciences Inc. potentialJuly 2025 Pullbacks & Safe Entry Point Identification - newser.com
Precision BioSciences: Q3 Earnings Snapshot - CT Insider
Precision BioSciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Precision BioSciences Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Multi asset correlation models including Precision BioSciences Inc.Earnings Performance Report & Technical Pattern Alert System - newser.com
Is Precision BioSciences Inc. stock a defensive play in 20252025 Support & Resistance & High Yield Stock Recommendations - newser.com
Precision BioSciences (DTIL) Exceeds Q3 Revenue Expectations - GuruFocus
Precision BioSciences Inc Reports Q3 2025 EPS of -$1.84, Missing - GuruFocus
Precision BioSciences Q3 revenue falls sharply - TradingView
PRECISION BIOSCIENCES INC SEC 10-Q Report - TradingView
Precision BioSciences Reports Third Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance
Precision BioSciences to Report Third Quarter 2025 Financial Results on November 3, 2025 - MarketScreener
How Precision BioSciences Inc. stock trades during market volatilityQuarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com
Has Precision BioSciences Inc. found a price floorJuly 2025 Pullbacks & Growth Focused Stock Reports - newser.com
Imugene Issues Shares to Precision Biosciences, Marking Milestone Achievement - TipRanks
Imugene Issues Shares to Precision Biosciences Following Milestone Achievement - TipRanks
Can Precision BioSciences Inc. stock resist market sell offsWeekly Profit Summary & Long-Term Capital Growth Strategies - newser.com
Is Precision BioSciences Inc. reversing from oversold territoryDollar Strength & Entry and Exit Point Strategies - newser.com
Imugene to Issue 19.5 Million Shares, Pay $3 Million in Cash to Precision Biosciences as Milestone Payment Under Licensing Agreement - MarketScreener
Will Precision BioSciences Inc. outperform the marketTrade Risk Summary & Step-by-Step Swing Trade Plans - newser.com
Momentum divergence signals in Precision BioSciences Inc. chartJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Is Precision BioSciences Inc. (PBS0) stock a top dividend aristocrat candidate2025 Trading Recap & Low Risk High Reward Ideas - newser.com
Imugene to explore discussions with FDA, triggering Precision BioSciences milestone - Proactive financial news
Real time breakdown of Precision BioSciences Inc. stock performanceMarket Performance Report & Reliable Breakout Forecasts - newser.com
Why millennials buy Precision BioSciences Inc. (PBS0) stockMarket Activity Recap & Weekly Momentum Picks - newser.com
Precision BioSciences, Inc. (NASDAQ:DTIL) Short Interest Update - MarketBeat
Is Precision BioSciences Inc. (PBS0) stock prepared for digital transitionPortfolio Update Report & High Yield Stock Recommendations - newser.com
Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns climbed after last week's 24% gain, institutional investors must be happy - Yahoo Finance
A great week that adds to Precision BioSciences, Inc.'s (NASDAQ:DTIL) one-year returns, institutional investors who own 46% must be happy - simplywall.st
Is Precision BioSciences Inc. stock positioned well for digital economyQuarterly Profit Summary & Verified Entry Point Signals - newser.com
Earnings visualization tools for Precision BioSciences Inc.July 2025 EndofMonth & Weekly Setup with High ROI Potential - newser.com
Is Precision BioSciences Inc. stock gaining market shareJuly 2025 Update & AI Driven Stock Reports - newser.com
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):